Fiserv
FISV
$52.37
-4.57%
Fiserv, Inc. is a leading global provider of financial services technology, offering core processing, electronic funds transfer, payment processing, and loan processing solutions primarily to U.S. banks, credit unions, and merchants. The company is a dominant, integrated player in the financial technology sector, formed from the 2019 merger with First Data, which expanded its footprint into merchant acquiring and payment processing. The current investor narrative is dominated by a high-profile, contrarian turnaround story, as the stock has faced severe pressure, evidenced by a 75% decline over the past year, but is now attracting attention from notable value investors betting on a recovery driven by operational stability and the execution of its strategic plan.…
FISV
Fiserv
$52.37
Related headlines
Investment Opinion: Should I buy FISV Today?
Rating: Hold. The core thesis is that FISV is a deeply undervalued but fundamentally challenged turnaround story where the risks of further operational deterioration currently balance the potential for a contrarian recovery.
Supporting evidence includes a compelling forward P/E of 6.9x, a robust TTM free cash flow yield implied by the P/CF ratio of 6.0x, a solid ROE of 13.5%, and a manageable debt profile. However, these strengths are counteracted by stagnant 0.63% revenue growth, significant gross margin compression, and catastrophic stock price performance that has underperformed the S&P 500 by over 32% in the past year. The analyst community appears neutral, reflecting this high uncertainty.
The thesis would upgrade to a Buy if the company demonstrates a return to consistent low-single-digit revenue growth and stabilizes gross margins above 58% for two consecutive quarters. It would downgrade to a Sell if revenue turns negative YoY or if the debt-to-equity ratio rises above 1.3. Based on the current data, the stock is fairly valued for the high level of risk it presents; it is not overvalued given its low multiples, but it is also not clearly undervalued without evidence of operational improvement.
Sign up to view all
FISV 12-Month Price Forecast
FISV is a binary bet on a corporate turnaround where the valuation offers a compelling margin of safety, but the fundamentals have yet to provide a catalyst for recovery. The strong cash flow and low multiple create a floor, likely preventing a total collapse, but the stock lacks a clear path to rerating without demonstrable top-line growth and margin stabilization. The stance is neutral because the probability-weighted outcomes suggest limited near-term upside balanced against defined downside. We would upgrade to bullish on evidence of sustained margin recovery and any positive revenue inflection; we would downgrade to bearish on a breakdown below the $52.91 support level on worsening fundamentals.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Fiserv's 12-month outlook, with a consensus price target around $68.08 and implied upside of +30.0% versus the current price.
Average Target
$68.08
6 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
6
covering this stock
Price Range
$42 - $68
Analyst target range
Analyst coverage is limited, with only 5 analysts providing estimates, and institutional ratings show a neutral to cautiously optimistic bias, with recent actions including 'Equal Weight' from Wells Fargo and 'Buy' from Tigress Financial. The consensus recommendation leans neutral, with an average EPS estimate of $16.62 and average revenue estimate of $24.17 billion for the forward period, but a specific consensus price target and implied upside are not calculable from the provided data. The target range for EPS is tight, from $16.24 to $16.86, indicating strong agreement on near-term earnings potential, but the lack of price targets suggests high uncertainty on the appropriate multiple. The recent news of a major value investor, Seth Klarman, building a position is a notable catalyst that could signal a floor in sentiment, but the wide dispersion in the stock's 52-week price range ($52.91 to $191.91) underscores the extreme uncertainty and lack of consensus on the company's intrinsic value.
Bulls vs Bears: FISV Investment Factors
The evidence presents a classic, high-stakes turnaround battle. The bear case is supported by severe fundamental deterioration, most critically the near-zero revenue growth and gross margin compression, which validate the stock's catastrophic price decline. However, the bull case is gaining traction, anchored by an extreme valuation discount (6.9x forward P/E), robust cash generation, and a vote of confidence from a savvy value investor. Currently, the bear side has stronger evidence due to the concrete, ongoing operational challenges. The single most important tension in the investment debate is whether the company's strong profitability and cash flow can stabilize and fund a return to growth before margin pressures and debt concerns overwhelm the business. The resolution of this growth vs. margin pressure dynamic will determine if FISV is a value trap or a value opportunity.
Bullish
- Deeply Undervalued Forward P/E: The stock trades at a forward P/E of 6.9x based on consensus EPS of $16.62, representing a significant discount to its historical valuation and the broader technology sector. This low multiple suggests the market has priced in extreme pessimism, leaving substantial room for multiple expansion if the company's turnaround stabilizes.
- Robust Free Cash Flow Generation: Fiserv generates massive free cash flow, with TTM FCF of $4.324 billion. This strong cash generation provides a financial cushion, supports a manageable debt-to-equity ratio of 1.13, and offers flexibility to fund operations, reduce debt, or return capital to shareholders during its turnaround.
- High-Profile Contrarian Investor Interest: Legendary value investor Seth Klarman has built a major position, signaling a potential floor in sentiment. This endorsement from a respected contrarian suggests the stock's 75% decline over the past year may have created a compelling risk/reward opportunity for patient capital.
- Strong Profitability and ROE: Despite growth challenges, the company remains highly profitable with a Q4 net margin of 15.3% and a Return on Equity of 13.5%. This demonstrates the underlying strength of its core processing and payments franchises, providing a solid earnings base for a recovery.
Bearish
- Severe Revenue Growth Stagnation: Q4 2025 revenue grew a mere 0.63% year-over-year, and quarterly revenue has been volatile, peaking in Q2 2025 before declining. This flat trajectory indicates the company is struggling to find organic growth drivers, which is critical for justifying any valuation recovery.
- Gross Margin Compression: Gross margin compressed to 57.08% in Q4 2025 from 61.82% in Q2 2025, a decline of nearly 5 percentage points. This suggests potential pricing pressure, unfavorable business mix shifts, or rising costs, which directly threaten the company's profitability and cash flow generation.
- Catastrophic Long-Term Underperformance: The stock has declined 75% over the past year and underperformed the S&P 500 by over 32 percentage points in the last 12 months. This severe and sustained downtrend reflects deep-seated fundamental issues and a complete loss of investor confidence that may take years to rebuild.
- High Debt Load in a Turnaround: With a debt-to-equity ratio of 1.13, the company carries significant leverage. While currently manageable due to strong FCF, this debt burden increases financial risk and limits strategic flexibility during a period of operational uncertainty and stagnant growth.
FISV Technical Analysis
The stock is in a pronounced and sustained downtrend, with a 1-year price change of -3.30% and a YTD decline of -5.26%, significantly underperforming the S&P 500's 29.04% gain over the same period. Currently trading at $62.14, the price sits near the lower end of its 52-week range of $52.91 to $191.91, indicating it is trading at approximately 5% above its 52-week low, which suggests the stock is deeply oversold and may represent a value opportunity, though it also reflects severe fundamental challenges and negative sentiment. Recent momentum shows a significant divergence, with a strong 1-month rally of +12.06% sharply contrasting the longer-term downtrend, potentially signaling a short-term oversold bounce or the early stages of a mean reversion; however, the 3-month performance remains negative at -2.49%, and the stock's relative strength versus the market is deeply negative across all periods, including a -32.34 relative strength over one year. Key technical support is clearly defined at the 52-week low of $52.91, while resistance lies at the recent lower highs around $69.85 from early January; a decisive break above the $70 level would be a bullish signal for a trend change, while a breakdown below $52.91 could trigger another leg down. The stock's volatility is not explicitly quantified by beta in the data, but the dramatic 52-week range and a maximum drawdown of -22.83% over the provided 180-day period indicate it has exhibited extreme price swings, demanding careful risk management for any position.
Beta
—
—
Max Drawdown
-25.0%
Largest decline past year
52-Week Range
$52-$191
Price range past year
Annual Return
—
Cumulative gain past year
| Period | FISV Return | S&P 500 |
|---|---|---|
| 1m | -10.9% | +8.2% |
| 3m | -11.0% | +9.0% |
| 6m | -17.4% | +10.5% |
| 1y | — | +26.5% |
| ytd | -20.2% | +8.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
FISV Fundamental Analysis
Revenue growth has stagnated, with Q4 2025 revenue of $5.284 billion representing a mere 0.63% year-over-year increase, and the quarterly trend shows volatility with revenue peaking in Q2 2025 at $5.516 billion before declining sequentially. The single reported revenue segment, 'Processing and Services,' contributed $4.273 billion, but without segment growth rates, the overall flat trajectory suggests the company is struggling to find organic growth drivers amidst its turnaround. Profitability remains intact but is under pressure, with Q4 2025 net income of $811 million and a net margin of 15.3%; however, gross margin compressed to 57.08% in Q4 from 61.82% in Q2 2025, indicating potential pricing pressure or mix shift, while operating income of $1.171 billion yielded a 22.2% operating margin. The company is solidly profitable and generates substantial cash flow, with trailing twelve-month free cash flow of $4.324 billion, a robust current ratio of 1.03, and a manageable debt-to-equity ratio of 1.13. The strong free cash flow, which supports an ROE of 13.5%, indicates the company can fund operations and potential debt reduction internally, though the debt level warrants monitoring given the challenging operating environment.
Quarterly Revenue
$5.3B
2025-12
Revenue YoY Growth
+0.00%
YoY Comparison
Gross Margin
+0.57%
Latest Quarter
Free Cash Flow
$4.3B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is FISV Overvalued?
Given a positive net income of $811 million, the primary valuation metric is the P/E ratio. The trailing P/E is 10.6x, while the forward P/E is significantly lower at 6.9x, implying the market expects a substantial earnings recovery, with forward EPS estimates averaging $16.62. Compared to sector averages, the trailing P/E of 10.6x appears to be at a discount to the broader technology/services sector, though specific industry average data is not provided in the valuation dataset for a precise comparison. Historically, the stock's own valuation has collapsed from extreme levels; the current trailing P/E of 10.6x is near the bottom of its historical range observed in the data, which saw P/E ratios above 30x as recently as early 2025 and over 65x in 2021. Trading near historical valuation lows suggests the market has priced in significant pessimism, leaving room for multiple expansion if the turnaround proves successful, but it also reflects a fundamental deterioration from its prior growth profile.
PE
10.6x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 11x~66x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
7.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks center on the company's ability to reignite growth while defending profitability. Revenue growth has stagnated at 0.63% YoY, and gross margin compressed sharply from 61.82% to 57.08% over two quarters, indicating potential pricing power erosion. The debt-to-equity ratio of 1.13, while manageable, adds pressure in a high-interest rate environment, and the company's future is heavily dependent on the successful execution of its turnaround plan with limited visibility on growth catalysts.
Market & Competitive Risks are pronounced. The stock trades at a deep discount (forward P/E 6.9x) because the market has re-rated it from a growth story to a troubled turnaround, creating valuation compression risk even if operations stabilize. The company faces intense competition in both core banking processing and merchant acquiring from more agile fintechs and larger peers. Its significant underperformance versus the market (relative strength -32.34 over one year) also exposes it to sector rotation away from out-of-favor names.
Worst-Case Scenario involves a failure of the turnaround plan, leading to continued revenue declines, further gross margin compression, and a breach of debt covenants. This could trigger a loss of key clients, analyst downgrades, and a complete derating of the stock. The realistic downside is to re-test and break below the 52-week low of $52.91. From the current price of $62.14, this implies a potential loss of approximately -15%. A more severe bear case, factoring in a failed turnaround, could see the stock fall 30-40% from current levels, revisiting prices not seen in over a decade.
FAQ
The key risks are, in order of severity: 1) Operational Risk: Continued revenue stagnation and gross margin compression, as seen in the Q4 margin drop to 57.08%. 2) Sentiment & Liquidity Risk: The stock has underperformed the market by 32% over the past year, and low analyst coverage increases volatility. 3) Financial Risk: A debt-to-equity ratio of 1.13, while manageable, limits flexibility during a turnaround. 4) Competitive Risk: Intense competition in fintech could pressure pricing and market share further.
Our 12-month outlook presents three scenarios. The Base Case (55% probability) sees the stock trading between $62 and $75 as it muddles through with flattish results. The Bull Case (25% probability), driven by a successful turnaround, targets $85 to $105. The Bear Case (20% probability), involving further deterioration, sees a drop to $48-$55. The base case is most likely, assuming the company stabilizes but fails to reignite meaningful growth. The key assumption is that strong free cash flow provides a valuation floor.
Based on traditional multiples, FISV appears deeply undervalued. It trades at a forward P/E of 6.9x and a P/CF of 6.0x, which are at or near historical lows for the company and a discount to the technology sector. However, this valuation reflects severe fundamental challenges, including near-zero growth and margin pressure. The market is pricing the stock as a troubled, no-growth entity. Therefore, it is fairly valued for its current risk profile rather than being a clear-cut bargain without a recovery thesis.
FISV is a speculative buy only for contrarian, value-oriented investors comfortable with high risk. The stock's forward P/E of 6.9x and robust $4.3 billion in annual free cash flow suggest significant pessimism is priced in, offering a margin of safety. However, with revenue growth stagnant at 0.63% and gross margins compressing, it is a pure turnaround bet with no near-term growth catalyst. For most investors, it is not a good buy until there is concrete evidence of operational improvement.
FISV is strictly a long-term, multi-year investment for investors betting on a turnaround. The company's challenges are structural and will not be resolved quickly. The stock's high volatility, evidenced by a 22.83% maximum drawdown in 180 days and a 75% decline over the past year, makes it unsuitable for short-term trading. A patient investor must be prepared to hold for 3-5 years to allow the strategic plan to unfold. There is no dividend, so the entire return is dependent on capital appreciation from a successful recovery.